Skip to main content

Press Releases

Month Year

Month Year

May 27, 2008

Node-Negative Early Stage Breast Cancer Patients Benefit From Taxotere®-Based Chemotherapy

First Phase III study performed solely in high risk, node-negative high risk population to show significant improvement in Disease Free Survival (DFS)
May 22, 2008

ATHENA Clinical Results with Dronedarone (Multaq®) Highlighted at the World Cardiology Congress
May 21, 2008

Sanofi-aventis Teams with HHS Quality Agency to Distribute Consumer Health Materials

AHRQ Materials Geared to Health Care Professionals & Patients
May 15, 2008

District Court Decision Affirmed in U.S. Lovenox® (enoxaparin sodium) Patent Infringement Case
May 15, 2008

Landmark ATHENA Study Findings With Multaq® (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
May 13, 2008

Sanofi-aventis named One of Best Employers for Healthy Lifestyles by National Business Group on Health
May 5, 2008

New Study Confirms Dose-Accuracy of SoloSTAR® Prefilled Insulin Pen

100% of Insulin Doses Administered Were Delivered Within Pre-Determined Guidelines and Standard Dosing Limitations
May 1, 2008

Sanofi-aventis: Encouraging First-Quarter 2008 Results; Further Positive Phase III Results for Eplivanserin
May 1, 2008

Sanofi-aventis Launches Teen Acne Awareness Program and Web Site

Web Site Provides Expert Advice and Answers to Acne-Related Questions
Apr 24, 2008

FDA Approves New Once-A-Month Dose Of Actonel® for Postmenopausal Osteoporosis

Show per page

Print
Email page
RSS